BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1062009)

  • 21. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
    Kaufman S; Brière J; Bernard J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of breast cancer with myeloproliferative disorders.
    Cornfield DB; Binder RA; Rath CE
    South Med J; 1977 Jul; 70(7):780-3. PubMed ID: 195348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE MYELOPROLIFERATIVE DISORDERS.
    ISRAUELS MC
    Scott Med J; 1965 Jun; 10():225-34. PubMed ID: 14337320
    [No Abstract]   [Full Text] [Related]  

  • 24. Myeloproliferative neoplasms cause glomerulopathy.
    Said SM; Leung N; Sethi S; Cornell LD; Fidler ME; Grande JP; Herrmann S; Tefferi A; D'Agati VD; Nasr SH
    Kidney Int; 2011 Oct; 80(7):753-9. PubMed ID: 21654720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When to use chemotherapy for chronic hematopoietic neoplasms.
    Yu KP; Krakoff IH
    Postgrad Med; 1968 May; 43(5):176-83. PubMed ID: 5239464
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Sankar K; Stein BL; Rampal RK
    Cancer Treat Res; 2019; 179():159-178. PubMed ID: 31317487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [THE MYELOPROLIFERATIVE SYNDROME FROM THE VIEWPOINT OF CLINICAL HEMATOLOGISTS].
    KUNZ G
    Z Gesamte Inn Med; 1964 Dec; 19():SUPPL:194-7. PubMed ID: 14235899
    [No Abstract]   [Full Text] [Related]  

  • 28. Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
    Habberstad AH; Tran HTT; Randen U; Spetalen S; Dybedal I; Tjønnfjord GE; Dahm AEA
    J Med Case Rep; 2018 Apr; 12(1):105. PubMed ID: 29685167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases.
    García-Manero G; Schuster SJ; Patrick H; Martinez J
    Am J Hematol; 1999 Feb; 60(2):130-5. PubMed ID: 9929105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoma of the breast, chronic lymphocytic leukemia, macroglobulinemia, eosinophilic chloroma and myelosclerosis--a unique association.
    Benvenisti DS; DeBellis RH
    Cancer; 1969 May; 23(5):1204-9. PubMed ID: 4976031
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [MYELOPROLIFERATIVE SYNDROMES].
    PIRESWDA F
    Folha Med; 1964 Apr; 48():195-201. PubMed ID: 14271209
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states.
    Martinez J; Shapiro SS; Holburn RR
    Blood; 1973 Jul; 42(1):35-46. PubMed ID: 4736876
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cytogenetic aspects of secondary leukemias].
    Alimena G; De Cuia MR; Gastaldi R; Lombardi A; Dallapiccola B
    Recenti Prog Med; 1981 Mar; 70(3):271-84. PubMed ID: 6941351
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythrocytosis and marked leukocytosis in overlapping myeloproliferative diseases.
    Shenkenberg TD; Waddell CC; Rice L
    South Med J; 1982 Jul; 75(7):868-9. PubMed ID: 6953606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MYELOPROLIFERATIVE DISORDERS].
    MARCIACQ ALTAFULLA
    Arch Med Panamenos; 1963 Aug; 12():149-59. PubMed ID: 14164997
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic myeloproliferative diseases.
    de Lacerda JF; Oliveira SN; Ferro JM
    Handb Clin Neurol; 2014; 120():1073-81. PubMed ID: 24365372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycythemia vera. II. Transgression towards leukemia with special emphasis on histological differential diagnosis, cytogenetics and survival.
    Vykoupil KF; Thiele J; Stangel W; Krmpotic E; Georgii A
    Virchows Arch A Pathol Anat Histol; 1980; 389(3):325-41. PubMed ID: 6935867
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comprehensive care of patients with thrombocythemia].
    Hrubisková K; Steruská M; Horváth A
    Vnitr Lek; 1987 Oct; 33(10):872-82. PubMed ID: 3479860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.